Want to join the conversation?
$BRC's 4Q16 revenues were almost in line with expectations, finishing with lower organic sales of 0.9%. Demand has been choppy and profitability stronger than anticipated, as the company focuses on driving operational efficiencies and actively reducing its G&A structure, said CFO Aaron Pearce.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?